drugset / Trial / NCT02561871
A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to assess the safety and tolerability of intramuscular prime-boost regimens of Ad26.RSV.FA2 given either once or twice followed by Ad35.RSV.FA2 (human adenovirus-vectored vaccine candidate) in healthy participants.
Timeline
- Start
- 2015-09
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ad26.RSV.FA2 | Vaccine | 5e+10 unknown | Intramuscular |
| Subject | Ad35.RSV.FA2 | Vaccine | 1e+11 unknown | Intramuscular |